Zobrazeno 1 - 10 of 418 pro vyhledávání: '"A. W. Langer"'
1
Akademický článek
Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas
Autor: Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge, Andreas Kjaer, Richard P. Baum
Publikováno v: Diagnostics, Vol 14, Iss 9, p 907 (2024)
The present report describes the history of a 58-year-old woman with a rapidly progressing neuroendocrine pancreatic tumor (initially G2) presenting with extensive liver, bone, and lymph node metastases. Previous treatments included chemotherapy, hem
Externí odkaz: https://doaj.org/article/954bf3749ed14039a4459a0950bb60ba
Zobrazit plný text záznamu
5
Prospective Phase II Trial of Prognostication by (68)Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
Autor: Esben Andreas Carlsen, Mathias Loft, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge, Andreas Kjaer
Publikováno v: J Nucl Med
Carlsen, E A, Loft, M, Loft, A, Berthelsen, A K, Langer, S W, Knigge, U & Kjaer, A 2022, ' Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy ', Journal of Nuclear Medicine, vol. 63, no. 9, pp. 1371-1377 . https://doi.org/10.2967/jnumed.121.263177
The clinical course for patients with neuroendocrine neoplasms (NENs) ranges from indolent to highly aggressive. Noninvasive tools to improve prognostication and guide decisions on treatment are warranted. Expression of urokinase plasminogen activato
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6deb2377261c2df148ea296215d2e74
https://europepmc.org/articles/PMC9454472/
Zobrazit plný text záznamu
6
Akademický článek
Primary pulmonary adenocarcinoma in a 16-year-old boy – a five-year follow-up
Autor: Ane Stillits Måreng, Seppo W. Langer, Uffe Bodtger
Publikováno v: European Clinical Respiratory Journal, Vol 3, Iss 0, Pp 1-3 (2016)
Primary pulmonary adenocarcinoma in children or adolescents is a rare disease, and as such, there are no randomised studies on lung cancer for this age group. Treatment choice is extrapolated from studies in adults (mean age of participants: 60 years
Externí odkaz: https://doaj.org/article/4f74299e285a439aa2a9d71f40c67689
Zobrazit plný text záznamu
8
18F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study
Autor: Birgitte Federspiel, Anne Kiil Berthelsen, Jann Mortensen, Peter Oturai, Camilla Bardram Johnbeck, Andreas Kjaer, Ulrich Knigge, Seppo W. Langer, Annika Loft, Tina Binderup
Publikováno v: J Nucl Med
Accurate grading of patients with neuroendocrine neoplasms (NENs) is essential for risk stratification and optimal choice of therapy. Currently, grading is based on histologically assessed degree of tumor proliferation. The aim of the present study w
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b92c33ef55754ad08ad6ce06fce9595
https://doi.org/10.2967/jnumed.120.244798
Zobrazit plný text záznamu
9
64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
Autor: Esben Andreas Carlsen, Annika Loft, Helle Hjorth Johannesen, Tina Binderup, Andreas Klaus Pfeifer, Seppo W. Langer, Jann Mortensen, Ulrich Knigge, Anne Kiil Berthelsen, Mathias Loft, Peter Oturai, Camilla Bardram Johnbeck, Andreas Kjaer
Publikováno v: Loft, M, Carlsen, E A, Johnbeck, C B, Johannesen, H H, Binderup, T, Pfeifer, A, Mortensen, J, Oturai, P, Loft, A, Berthelsen, A K, Langer, S W, Knigge, U & Kjaer, A 2021, ' 64 Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms : Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours Post-Injection ', The Journal of Nuclear Medicine, vol. 62, no. 1, pp. 73-80 . https://doi.org/10.2967/jnumed.120.244509
64Cu-DOTATATE PET/CT imaging 1 hour (h) post-injection (p.i.) is excellent for lesion detection in patients with neuroendocrine neoplasms (NEN). We hypothesized that the imaging time window can be extended up to 3h p.i. without significant difference
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fab391305cb05e4aca110c9a3d9610a4
https://doi.org/10.2967/jnumed.120.244509
Zobrazit plný text záznamu
10
P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
Autor: Tina Binderup, Andreas Kjaer, Birgitte Federspiel, Veronica Grøndahl, Seppo W. Langer, Linea Melchior, Ulrich Knigge, Kirstine Nielsen, Pauline Knigge
Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Nielsen, K, Binderup, T, Langer, S W, Kjaer, A, Knigge, P, Grøndahl, V, Melchior, L, Federspiel, B & Knigge, U 2020, ' P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms ', BMC Cancer, vol. 20, 27 . https://doi.org/10.1186/s12885-019-6498-z
BMC Cancer
Background High grade gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) with a Ki67 proliferation index > 20%, include well-differentiated tumours grade 3 (NET G3) and poorly differentiated (PD) neuroendocrine carcinomas (NEC). Abnormal p53
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d93255a464ae954445e87947288cacf
https://doaj.org/article/c384757899ea4148bfbfb4d4284db073
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje